Kristin J. Moore, n/a

Associate Director, Real World Evidence, Oncology
Jazz Pharmaceuticals plc, Dublin, Ireland, Ireland

Poster(s):

• (225) Treatment Patterns, Healthcare Resource Utilization (HCRU), and Costs in Adolescent and Young Adult (AYA) Patients (Pts) With Acute Lymphoblastic Leukemia (ALL)
  Wednesday, October 29, 2025

• (328) Healthcare resource utilization (HCRU) and costs during second-line (2L) treatment for small-cell lung cancer (SCLC)
  Wednesday, October 29, 2025